Document is current
Any future updates will be listed below
-
Authors
Bermejo-Peláez, David http://orcid.org/0000-0002-0181-3957
Alastruey-Izquierdo, Ana http://orcid.org/0000-0001-8651-4405
Medina, Narda http://orcid.org/0000-0001-6176-0052
Capellán-Martín, Daniel http://orcid.org/0000-0002-9743-0845
Bonilla, Oscar http://orcid.org/0000-0003-4227-3632
Luengo-Oroz, Miguel http://orcid.org/0000-0002-8694-2001
Rodríguez-Tudela, Juan Luis
-
Funding
Funding for this research was provided by:
GAFFI
JYLAG
Instituto de Salud Carlos III (PI20CIII/00043)
Agencia Estatal de Investigación (PTQ2020-011340/AEI/10.13039/501100011033)
- License Information
-
More Information
Article History
Received: 5 March 2024
Accepted: 25 July 2024
First Online: 30 August 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was not subject to IRB review because no human experiments were performed. Informed consent is not applicable.
: Not applicable.
: We, the authors, give our consent for the publication of this manuscript and related content in IMA Fungus.
: DB-P, DC-M and ML-O work for Spotlab. AA-I has received honoraria for educational talks on behalf of Gilead and Pfizer, outside of the submitted work.
